Milkeesso Foge, MD

Seasoned Hospitalist with expertise in patient care and clinical management. Equipped with strong problem-solving abilities, willingness to learn, and excellent communication skills. Poised to contribute to team success and achieve positive results. Ready to tackle new challenges and advance organizational objectives with dedication and enthusiasm.

• Internal Medicine - American Board of Hospital Medicine
• Advanced Cardiac Life Support (ACLS) - American Heart Association

• Hooks, M.C.,Nijjar.P., Chen.K., Wang.M.. Foge, M.,Cullen,R.,Maganti,T.,Blaes,A.,Shenoy,C..Rates of clinical reporting and action taken based on coronary calcium on cancer CT scans in patients at risk for cardiovascular disease after potentially cardiotoxic cancer treatment. Journal of American College of Cardiology. 2019, March;73(9):33781-7

• Sharma, M., Foge, M., Mascarenhas, D., A Suspected Case of Hydralazine-Induced Hepatotoxicity: A Case Report and Review of Literature. American Journal of Case Reports, 2018; 19: 800-803

07/2009 - 06/2010

National Institute of Health, Bethesda, MD, United States

Post-Baccalaureate Fellow, Stewart Levine, MD

Selected to the Intramural Research Training Award (IRTA) Program at the NIH, a competitive one year research fellowship. Joined a laboratory focused on identifying new diagnostic & therapeutic approaches in severe asthma. Studied mice model of severe asthma (unresponsive to corticosteroids). Identified apolipoprotein E (ApoE) as potential treatment of asthma. Collected Exhaled Breath Condensate (EBC) from severe asthma patients and conducted proteomic analysis of the condensate.